NEW YORK — Agilent Technologies said this week that it has received California state clinical laboratory license and CLIA certification allowing the company to launch its Biopharma CDx Services Lab in Carpinteria, California. The lab will be used to support drug development with companion diagnostic development. The company said that the lab offers innovative technologies that can be used to help assess biomarkers as well as assays that can help customers to generate robust data.
Sophia Genetics said this week that it has expanded a previously announced partnership with AstraZeneca designed to increase global access to the MSK-ACCESS liquid biopsy test powered by the Sophia DDM informatics platform. The next stage of the partnership will see Sophia and AstraZeneca deploy MSK-ACCESS to 20 undisclosed locations worldwide over the next 12 months. Additionally, through a real-world evidence study, researchers will be able to evaluate the operational benefits of liquid biopsy testing, including the speed of results and the ability of users to consistently achieve high-quality data in a variety of laboratory settings, Sophia said. MSK-ACCESS is a decentralized version of a circulating tumor DNA test developed by Memorial Sloan Kettering Cancer Center that combines the Sohpia DDM platform with MSK's scientific and clinical expertise.
Danaher this week announced that its board of directors has approved a regular quarterly cash dividend of $.27 per share of its common stock, payable on Oct. 25 to shareholders of record on Sept. 27.
Thermo Fisher Scientific this week announced the recipients of this year's Oncomine Clinical Research Grant. The winners include researchers from Tata Memorial Centre in India, Leiden University Center in the Netherlands, Western University in Canada, and Fred Hutch Cancer Center in the US. Thermo Fisher said the recipients are "awarded reagents and general funding" but did not disclose the exact amount.
In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on 360Dx.